Completed

Phase 2
Age: 20Years - 55Years
All Genders
ID00000294

Effects of Carvedilol on Cocaine Use in Humans

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

U

University of Minnesota

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to examine carvedilol effects in response to cocaine.

CONDITIONS

Official Title

Effects of Carvedilol on Cocaine Use in Humans - 11

Who Can Participate

Age: 20Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Male/Female between 20 and 55. History of smoked or intravenous cocaine use on the average of at least once a week over a 6 month period. current history of good health and normal EKG. Not pregnant as determined by pregnancy screening nor breast feeding, using acceptable birth control methods (e.g. birth control pills diaphragm, condoms plus foam)

Not Eligible

You will not qualify if you...

Current problems with major psychiatric illnesses including bipolar disorder, schizophrenia, or anxiety disorders. History of major medical illnesses including asthma and chronic obstructive pulmonary disease. Currently on a drug related parole or probation. Treated for chemical dependency withing the past 6 months.

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here